ChromaDex Corporation Reports Third Quarter 2018 Financial Results
07 nov. 2018 16h01 HE
|
ChromaDex Corporation
- Third Quarter 2018 Net Revenues Increased by 33% to $8.1 Million - Third Quarter 2018 Highlights vs. Third Quarter 2017 Net sales up 33%, fueled by growth of TRU NIAGEN®, which increased by...
ChromaDex Appoints Matthew Roberts as Chief Scientific Officer and Senior Vice President of Innovation
06 nov. 2018 06h30 HE
|
ChromaDex Corporation
LOS ANGELES, Nov. 06, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced today that it has appointed Matthew Roberts as Chief Scientific Officer and Senior Vice President of...
ChromaDex to Report Third Quarter 2018 Financial Results on Wednesday, November 7, 2018
31 oct. 2018 16h05 HE
|
ChromaDex Corporation
LOS ANGELES, Oct. 31, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced that it will hold a conference call on Wed., Nov. 7, 2018 at 4:30 p.m. Eastern time to discuss its financial...
TRU NIAGEN® Recognized as Best Product & Most Popular Brand at Health, Wellness & Beauty Awards 2018 of Watsons Hong Kong
30 oct. 2018 06h30 HE
|
ChromaDex Corporation
TRU NIAGEN® (nicotinamide riboside) receives best product award and recognized as top seller in 2018 amongst Watsons Hong Kong members LOS ANGELES, Oct. 30, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp....
TRU NIAGEN® to be Featured at One-Day Medical School at Yale University School of Medicine
25 oct. 2018 06h30 HE
|
ChromaDex Corporation
Inaugural event aims to empower women on critical health issues that arise after age 45 LOS ANGELES, Oct. 25, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced today its TRU...
TRU NIAGEN® Daily Serving Strengthened Under FDA’s NDI Notification
24 oct. 2018 06h30 HE
|
ChromaDex Corporation
ChromaDex increases capsule serving to 150mg TRU NIAGEN® (nicotinamide riboside), following successful New Dietary Ingredient (NDI) notification from FDA LOS ANGELES, Oct. 24, 2018 (GLOBE NEWSWIRE)...
Science Behind TRU NIAGEN® to be Featured at the World Mitochondria Society Meeting
22 oct. 2018 06h30 HE
|
ChromaDex Corporation
Frank Jaksch to speak on healthy aging and the research supporting TRU NIAGEN® in Berlin LOS ANGELES, Oct. 22, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced today that it will...
TRU NIAGEN® PRO to be Featured at the North American Menopause Society (NAMS) Annual Meeting
03 oct. 2018 06h30 HE
|
ChromaDex Corporation
LOS ANGELES, Oct. 03, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced today that it will highlight its new TRU NIAGEN® PRO product at the NAMS Annual Meeting 2018 in San Diego, CA,...
ChromaDex Appoints Yan Chu as Managing Director, Asia Pacific
02 oct. 2018 06h30 HE
|
ChromaDex Corporation
LOS ANGELES, Oct. 02, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced today that it has appointed Yan Chu as Managing Director, Asia Pacific, effective today. Based in Singapore,...
TRU NIAGEN® Earns NSF International’s Certified for Sport® Certification
24 sept. 2018 06h30 HE
|
ChromaDex Corporation
IRVINE, Calif., Sept. 24, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to improving the way people age with its flagship...